Metastatic mucinous carcinomas in the ovary: A practical approach to diagnosis related to gross aspects and to immunohistochemical evaluation

International Journal of Gynecological Pathology

Volumn 31, Issue 4, 2012, Pages 313-318

  Pinto, Paola B Cardoso ^a   Derchain, Sophie F M ^a   De Angelo Andrade, Liliana Aparecida Lucci ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Algorithm; Immunohistochemistry; Metastases; Mucinous carcinoma; Ovary

Indexed keywords

BETA CATENIN; HORMONE RECEPTOR; SMAD4 PROTEIN; TRANSCRIPTION FACTOR CDX2; WT1 PROTEIN;

ADULT; AGED; ALGORITHM; ARTICLE; BILATERAL CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EVALUATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MEDICAL LITERATURE; MEDICAL RECORD REVIEW; METASTASIS; MUCINOUS CARCINOMA; OVARY CARCINOMA; PRIORITY JOURNAL; TISSUE MICROARRAY; TUMOR VOLUME;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ALGORITHMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862278711     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0b013e31823f844d     Document Type: Article

References (22)

1. Seidman JD, Horkayne-Szakaly I, Haiba M, et al. The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int J Gynecol Pathol 2004;23:41-4.
2. Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 2003;27:985-93.
3. Logani S, Oliva E, Arnell PM, et al. Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma. Mod Pathol 2005;18:19-25.
4. Riopel MA, Ronnett BM, Kurman RJ. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: Atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol 1999;23:617-35.
5. Yemelyanova AV, Vang R, Judson K, et al. Distinction of primary and metastatic mucinous tumors involving the ovary: Analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification. Am J Surg Pathol 2008;32:128-38.
6. Young RH, Hart WR. Metastases from carcinomas of the pancreas simulating primary mucinous tumors of the ovary. A report of seven cases. Am J Surg Pathol 1989;13:748-56.
7. Young RH, Scully RE. Ovarian metastases from carcinoma of the gallbladder and extrahepatic bile ducts simulating primary tumors of the ovary. A report of six cases. Int J Gynecol Pathol 1990;9:60-72.
8. Moore RG, Chung M, Gramai CO, et al. Incidence of metastasis to the ovaries from non genital tract primary tumors. Gynecol Oncol 2004;93:87-91.
9. Vang R, Ronnett BM. Distinction of primary ovarian mucinous tumors and mucinous tumors metastatic to the ovary: A practical approach with guidelines for prediction of primary site for metastasis of uncertain origin. Pathol Case Rev 2006;11:18-30.
10. Ulbright TM, Roth LM, Stehman FB. Secondary ovarian neoplasia. A clinicopathologic study of 35 cases. Cancer 1984;53:1164-74.
11. Young RH. From Krukenberg to today: The ever present problems posed by metastatic tumors in the ovary: part I. Historical perspective, general principles, mucinous tumors including the Krukenberg tumor. Adv Anat Pathol 2006;13:205-27.
12. Kiyokawa T, Young RH, Scully RE. Krukenberg tumors of the ovary: A clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol 2006;30:277-99.
13. Soslow RA. Histologic subtypes of ovarian carcinoma: An overview. Int J Gynecol Pathol 2008;27:161-74.
14. Ji H, Isacson C, Seidman JD, et al. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Int J Gynecol Pathol 2002;21:391-400.
15. Vang R, Gown AM, Wu LSF, et al. Immunohistochemical expression of CDX2 in primary ovarian mucinous carcinomas involving the ovary: Comparison with CK20 and correlation with coordinate expression of CK7. Mod Pathol 2006;19: 1421-28.
16. Lugli A, Tzankov A, Zolbec I, et al. Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/ CK7 in colorectal cancer stratified by mismatch repair status. Mod Pathol 2008;21:1403-12.
17. Fraggeta F, Pelosi G, Cafici A, et al. Cdx-2 immunoreactivity in primary and metastatic ovarian mucinous tumors. Virchows Arch 2003;443:782-86.
18. Tornillo L, Moch H, Diener PA, et al. CDX-2 immunostaining in primary and secondary ovarian carcinomas. J Clin Pathol 2004;57:641-43.
19. Tabrizi AD, Kalloger SE, Kö bel M, et al. Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases. Int J Gynecol Pathol 2010;29:99-107.
20. McCluggage WG, Wilkinson N. Metastatic neoplasms involving the ovary: A review with emphasis on morphological and immunohistochemical features. Histopathology 2005;47: 231-47.
21. Zaino RJ, Brady MF, Lele SM, et al. Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal. Cancer 2011;117:554-62.
22. Soslow RA. Mucinous ovarian carcinoma: slippery business. Cancer 2011;117:451-3.